May 02, 2024 / 11:00AM GMT
Operator
Gentlemen, good day and welcome to Ajanta Pharma Q4 FY24 earnings conference call. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Yogesh Agrawal, Managing Director of Ajanta Pharma Limited. Thank you and over to you sir.
Yogesh Agrawal - Ajanta Pharma Ltd - Managing Director, Executive Director
Thank you. Good evening and welcome to all of you. With me, I have Mr. Rajesh Agrawal, Joint Managing Director, Mr. Arvind Agrawal, our CFO, Mr. Rajiv Agrawal, our A&D Finance and Investor Relation. Friends, we have a technical slag in uploading the list, so it just got uploaded short while back. My apologies for the same. But for the benefit of all the listeners who have joined, I will just read out the highlights of the performance of the quarter and then I will take you through the performance of each vertical for this quarter too.
So for Q4 FY24, our performance highlights as compared to the year-over-year are, revenue from the operations are at INR1,054 crore against INR82 crore up by 20%
Q4 2024 Ajanta Pharma Ltd Earnings Call Transcript
May 02, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers